These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8619912)

  • 1. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Ismaeel NA
    Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
    Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
    Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
    Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR; Hujer AM; Helfand MS; Bonomo RA
    FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods.
    Nicodemo AC; Araujo MR; Ruiz AS; Gales AC
    J Antimicrob Chemother; 2004 Apr; 53(4):604-8. PubMed ID: 14973153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
    Köseoğlu O; Sener B; Gür D
    Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the antibiotic sensitivity of Pseudomonas sp. using the API-ATB-PSE system. Comparison with diffusion and the reference agar dilution method].
    Delisle F; Lesage D; Gayral JP; Daguet GL; Vergez P; Le Cunff D
    Pathol Biol (Paris); 1986 May; 34(5):424-9. PubMed ID: 3534715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
    Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
    Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between agar dilution and three other methods for determining the susceptibility of 228 clinical isolates of non-fermenting gram-negative rods].
    Gómez-Garcés JL; Aracil B; Gil Y
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):331-7. PubMed ID: 19406523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness.
    Tatman-Otkun M; Gürcan S; Ozer B; Aydoslu B; Bukavaz S
    BMC Microbiol; 2005 May; 5():24. PubMed ID: 15882456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
    Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
    Ekşi F; Ozer G; Balci I
    Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
    Smit WJ; Boquest AL; Geddes JE; Tosolini FA
    Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.